Japanese Pharmaceuticals & Biotech Price disconnect

Results

0 new

Stocks which the market has priced substantially different to their cash flows, which could imply risk.

2 companies

Astellas Pharma

Market Cap: JP¥3.9t

Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.

4503

JP¥2,213.50

2.0%

60.2%

Sumitomo Pharma

Market Cap: JP¥698.5b

Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.

4506

JP¥1,546.50

1.1%

70.7%